OLMA

OLEMA PHARMACEUTICALS INC

OLMA·68062P106·US·Common Stock·Healthcare - Biotechnology-Activist

OLMA (OLEMA PHARMACEUTICALS INC) is held by 118 institutional investors as of Q1 2026. Largest holders: FMR LLC ($154.9M), Janus Henderson Group Ltd. ($106M), BlackRock, Inc. ($84.3M). Net institutional sentiment: Mixed.

118
Holders
Avg rating(25 Elite)
$883.1M
Total Value
65% (136)
Fund Consensus
82 buying - 44 selling
OLMASmart Money Verdict
View all
Held by 118 funds
25 elite
Who's Trading
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC8.2%May 15, 2026
ActivistBLBain Capital Life Sciences Opportunities IV, L.P.8.2%May 15, 2026
ActivistIPInvus Public Equities, L.P.4.5%Mar 20, 2026
ActivistFMR LLCFMR LLC12.5%Mar 6, 2026
InsiderMSMitchell ShawnteSell $601KMar 4, 2026
InsiderMSMitchell ShawnteSell $6KMar 4, 2026
InsiderMSMitchell ShawnteSell $345KMar 3, 2026
ActivistBLBain Capital Life Sciences Opportunities IV, L.P.10.0%Feb 17, 2026
ActivistDTDeep Track Capital, LP0.0%Feb 13, 2026
InsiderHCHarmon CyrusSell $269KJan 20, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
10.4M(+106.8%)$154.9M0.0%-50.72%
49
Increased
7.1M(+5.9%)$106M0.1%-20.87%
32
Increased
5.7M(+1.6%)$84.3M0.0%+36.74%
30
Increased
3.9M(+109.0%)$58.7M0.0%-41.00%
48
New
3.1M$46M0.0%-49.17%
40
Unchanged
2.6M$38.8M0.4%-52.49%
0
Increased
1.8M(+89.0%)$27.2M0.0%-50.98%
45
Increased
1.6M(+16.1%)$23.9M0.1%-52.06%
33
Increased
1.5M(+22.8%)$23M0.0%-16.22%
35
Increased
1.5M(+0.0%)$22.1M0.1%+71.50%
28
Decreased
1.2M(-50.8%)$18.2M0.0%+178.34%
0
Increased
1.2M(+82.6%)$18.1M0.0%-13.02%
44
Increased
1.2M(+7.9%)$17.6M0.0%-51.20%
31
Increased
1.2M(+197.1%)$17.4M0.0%-47.13%
46
Increased
1.1M(+12.9%)$16.1M0.0%+14.30%
32
Increased
1M(+27.8%)$15.6M0.0%+24.75%
35
New
986,827$14.7M0.4%-49.17%
46
Decreased
905,332(-24.6%)$13.5M0.0%+12.62%
0
Increased
759,513(+11.8%)$11.3M0.1%-2.62%
31
Increased
738,552(+124.7%)$11M0.0%-49.97%
45

Showing 1-20 of 136

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used